Try our Advanced Search for more refined results
June 14, 2013
INSITE VISION INCORPORATED et al v. MYLAN PHARMACEUTICALS INC. et al
Case Number:
3:13-cv-03720
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 17, 2013
Merck, Pfizer Sue Mylan Over Generic Eye Drug Application
Pfizer Inc., Merck Sharp & Dohme Corp. and InSite Vision Inc. banded together Monday to slam Mylan Pharmaceuticals Inc. with an infringement suit in New Jersey federal court, alleging Mylan's application to market a generic version of the eye drug AzaSite violates four of their patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login